SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-18-008824
Filing Date
2018-08-10
Accepted
2018-08-10 16:27:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 ndra_s3.htm S-3 414199
2 OPINION OF K&L GATES LLP ndra_ex51.htm EX-5.1 15700
3 CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ndra_ex231.htm EX-23.1 4182
4 IMAGE ndra_ex51000.jpg GRAPHIC 2302
5 IMAGE ndra_s3000.jpg GRAPHIC 5490
6 IMAGE ndra_s3001.jpg GRAPHIC 8216
7 IMAGE ndra_s3002.jpg GRAPHIC 25861
8 IMAGE ndra_s3003.jpg GRAPHIC 7225
  Complete submission text file 0001654954-18-008824.txt   503468
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226785 | Film No.: 181009172
SIC: 3845 Electromedical & Electrotherapeutic Apparatus